Logo image of ATEK

ATHENA TECHNOLOGY ACQUISIT-A (ATEK) Stock Fundamental Analysis

NYSEARCA:ATEK - NYSE Arca - US04687C1053 - Common Stock - Currency: USD

11.33  -0.59 (-4.95%)

Fundamental Rating

0

Taking everything into account, ATEK scores 0 out of 10 in our fundamental rating. ATEK was compared to 0 industry peers in the Unkown industry. ATEK may be in some trouble as it scores bad on both profitability and health. ATEK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ATEK has reported negative net income.
In the past year ATEK has reported a negative cash flow from operations.
ATEK Yearly Net Income VS EBIT VS OCF VS FCFATEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 0 1M -1M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -8.4%
ROE N/A
ROIC N/A
ROA(3y)1.87%
ROA(5y)N/A
ROE(3y)4.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATEK Yearly ROA, ROE, ROICATEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

ATEK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEK Yearly Profit, Operating, Gross MarginsATEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for ATEK has been reduced compared to 1 year ago.
ATEK has a worse debt/assets ratio than last year.
ATEK Yearly Shares OutstandingATEK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
ATEK Yearly Total Debt VS Total AssetsATEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 1.95 indicates that ATEK is not a great score, but indicates only limited risk for bankruptcy at the moment.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACCN/A
WACCN/A
ATEK Yearly LT Debt VS Equity VS FCFATEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

ATEK has a Current Ratio of 0.10. This is a bad value and indicates that ATEK is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.10 indicates that ATEK may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
ATEK Yearly Current Assets VS Current LiabilitesATEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ATEK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -207.13%.
EPS 1Y (TTM)-207.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-753.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEK Price Earnings VS Forward Price EarningsATEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEK Per share dataATEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATHENA TECHNOLOGY ACQUISIT-A

NYSEARCA:ATEK (12/9/2024, 8:04:01 PM)

11.33

-0.59 (-4.95%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-22 2024-11-22
Earnings (Next)N/A N/A
Inst Owners14.05%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap125.99M
AnalystsN/A
Price TargetN/A
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0
BVpS-0.12
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.4%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.87%
ROA(5y)N/A
ROE(3y)4.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 1.95
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-207.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-753.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.09%
OCF growth 3YN/A
OCF growth 5YN/A